The government is likely to revise the Uniform Code of Pharmaceutical Marketing Practices in 2023.
The drug, Leqembi, is the first that's been convincingly shown to slow the decline in memory and thinking that defines Alzheimer's by targeting the disease's underlying biology.
Over the past few days, the number of COVID-19 cases in India has risen marginally, owing to a jump in tests even though the test positivity rate stays very low.
The product will help in the management of inadequately controlled asthma by improving lung function, providing better symptom control and reducing exacerbations.
India has assumed the G20 presidency since December 1 last year and plans to highlight its severe healthcare initiatives, apart from COVID-19 management during the health working group meetings
Experts point out that laxity on the part of regulators has resulted in substandard and adulterated drugs hitting markets in India and other countries with weak regulatory oversight.
The weekly rolling average COVID-19 test positivity rate in India stood at 0.13 percent on January 3, way lower than the 5 percent level where it becomes alarming, by World Health Organization standards.
The government has sent a consignment list for supplying 80 lakh doses of Covishield to different consignees to Serum Institute of India, which will start the supply soon, an official said.
In India, prostate cancer usually affects men above 65 years of age. However, there has been an increase in reports of cancer in men in the age group of 35-44 and 55-64, mainly in urban areas.
In a statement released by her representative, the 18-time Grand Slam singles champion and member of the International Tennis Hall of Fame said her prognosis is good and she will start treatment this month.
Ribociclib is one of three drugs used to treat a specific type of breast cancer and is prohibitively expensive for many patients
Distressed patients said they broke down and felt "sick to their teeth" after receiving the terminal illness diagnosis.
A small study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling Covid.
A spate of allegations that contaminated drugs were being exported to countries with weak drug regulatory mechanisms indicates that larger reforms may be needed
Two back-to-back cases of cough syrups from India, the first one involving Maiden Pharmaceuticals, which was blamed for supplying contaminated drugs that killed 70 kids in Gambia, have tainted India’s image as the ‘Pharmacy of the World’
Drug authorities have asked the drug maker for an undertaking clarifying whether the Doc-1 Max syrup has been supplied in any part of India
Sources said that government officials inspected the manufacturing facility till late night and collected the Doc 1-Max cough syrup from the plant. Hasan Raza, Marion Biotech Pharma Company legal head also mentioned that the product has been halted.
Private healthcare providers say that the new clause in the CGHS contract will increase their financial stress.
The move comes nearly a month after a detailed inspection at the drug manufacturing unit of Maiden Pharmaceuticals in Haryana found several Good Manufacturing Practices violations
Air Suvidha form filling to declare current health status will be made compulsory for international passengers arriving from these countries as per the Centre's protocol.
According to government officials, an Indian bivalent vaccine – which uses two variations of the coronavirus strain – is already in the pipeline.
The COVID-19 vaccine will now be offered to the adults earlier fully vaccinated with Covaxin or Covishield after the government incorporated changes in the CoWin app.
Experts say it may be pointless administering multiple shots of existing COVID-19 vaccines even to those considered most susceptible. However, availability of bivalent or multiple vaccines that work against more than one strain should lead to a change in vaccination policy, they add.
The Union government’s failure to procure vaccine doses immediately may be seen as an indication that booster shots against COVID may be available only in the private market in days to come.
A sharp increase in coronavirus cases in China has sparked concern around the world. In India, Union Health Minister Mansukh Mandaviya briefed the parliament today about the evolving situation.